• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国器官移植数据系统。

The French organ transplant data system.

作者信息

Strang William Nigel, Tuppin Philippe, Atinault Alain, Jacquelinet Christian

机构信息

Agence de la biomédecine 1 avenue Stade de France 93212 SAINT DENIS LA PLAINE CEDEX France.

出版信息

Stud Health Technol Inform. 2005;116:77-82.

PMID:16160239
Abstract

The Agence de la Biomédecine is a state agency dealing with Public Health issues related, among others, to organ, tissue and cell transplantation in France. The Agence maintains a national information system used to coordinate and administer organ procurement and transplant activities and to perform the evaluation of organ transplantation activities. This paper describes the core uses and functional requirements of Cristal, the donor, recipient and allocation software of the information system and its evolution in the new system.

摘要

法国生物医学局是一个国家机构,负责处理与法国器官、组织和细胞移植等相关的公共卫生问题。该局维护着一个国家信息系统,用于协调和管理器官获取及移植活动,并对器官移植活动进行评估。本文介绍了该信息系统的捐赠者、接受者及分配软件Cristal的核心用途和功能要求,以及它在新系统中的演变情况。

相似文献

1
The French organ transplant data system.法国器官移植数据系统。
Stud Health Technol Inform. 2005;116:77-82.
2
[The role of the French Agence de la biomédecine in lung transplantation].
Rev Pneumol Clin. 2010 Feb;67(1):57-63. doi: 10.1016/j.pneumo.2010.12.008. Epub 2011 Feb 1.
3
New French heart allocation system: Comparison with Eurotransplant and US allocation systems.法国新的心脏分配系统:与 Eurotransplant 和美国分配系统的比较。
Am J Transplant. 2020 May;20(5):1236-1243. doi: 10.1111/ajt.15816. Epub 2020 Mar 3.
4
[Fundamentals of organ and tissue procurement].[器官与组织获取的基础]
Soins. 2023 Sep;68(878):10-15. doi: 10.1016/j.soin.2023.07.003. Epub 2023 Aug 17.
5
[Cost of a renal transplant: medico-economic analysis of the amount reimbursed by the French national health program to finance renal transplantation].
Nephrol Ther. 2014 Jul;10(4):228-35. doi: 10.1016/j.nephro.2014.01.009. Epub 2014 Jun 27.
6
A contextual coding system for transplantation and end stage diseases.一种用于移植和终末期疾病的情境编码系统。
Stud Health Technol Inform. 2003;95:457-62.
7
Design considerations for an ontology in the domain of organ failure and transplantation.器官衰竭与移植领域本体的设计考量
Stud Health Technol Inform. 2002;90:611-5.
8
Transplant coordinators and communication with potential organ donor migrant families in France: an exploratory qualitative study.法国的移植协调员与潜在器官捐献者移民家庭的沟通:一项探索性定性研究。
Transplant Proc. 2009 Mar;41(2):631-3. doi: 10.1016/j.transproceed.2008.12.009.
9
[Opposition to organ donation in France: marker of a growing social divide?].[法国对器官捐赠的反对:社会分化加剧的标志?]
Bull Acad Natl Med. 2013 Apr-May;197(4-5):911-20; discussion 920-23.
10
[Deceased donation in renal transplantation].[肾移植中的尸体捐赠]
Prog Urol. 2016 Nov;26(15):909-939. doi: 10.1016/j.purol.2016.08.021. Epub 2016 Oct 8.

引用本文的文献

1
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome.尿毒症负担指数:肾移植术前结果的新型预测指标。
Clin Kidney J. 2025 May 13;18(7):sfaf129. doi: 10.1093/ckj/sfaf129. eCollection 2025 Jul.
2
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients.小儿肾移植受者移植肾存活的移植前风险评估工具的国际验证
Clin Kidney J. 2025 Jan 28;18(3):sfaf031. doi: 10.1093/ckj/sfaf031. eCollection 2025 Mar.
3
COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy.
COVID-19 住院治疗与免疫抑制治疗的实体器官移植受者。
JAMA Netw Open. 2023 Nov 1;6(11):e2342006. doi: 10.1001/jamanetworkopen.2023.42006.
4
France's New Lung Transplant Allocation System: Combining Equity With Proximity by Optimizing Geographic Boundaries Through the Supply/Demand Ratio.法国新的肺移植分配系统:通过供需比优化地理边界,实现公平与接近相结合。
Transpl Int. 2022 May 24;35:10049. doi: 10.3389/ti.2022.10049. eCollection 2022.
5
The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study.心肌病的公共卫生负担:一项全国性住院患者研究的见解
J Clin Med. 2020 Mar 27;9(4):920. doi: 10.3390/jcm9040920.
6
End-stage renal disease treated in Provence-Alpes Côte d'Azur: 12-years follow-up and forecast to the year 2030.普罗旺斯-阿尔卑斯-蓝色海岸地区治疗的终末期肾病:12 年随访及 2030 年预测。
BMC Nephrol. 2018 Jun 15;19(1):141. doi: 10.1186/s12882-018-0929-y.
7
Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease.社会经济不平等对终末期肾病患者肾移植可及性和生存的影响。
PLoS One. 2016 Apr 15;11(4):e0153431. doi: 10.1371/journal.pone.0153431. eCollection 2016.
8
Are there good reasons for inequalities in access to renal transplantation in children?儿童肾移植获取机会不平等是否存在充分理由?
Nephrol Dial Transplant. 2015 Dec;30(12):2080-7. doi: 10.1093/ndt/gfu356. Epub 2014 Nov 23.
9
Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France.与肾移植受者健康相关生活质量相关的因素:法国全国调查结果。
Health Qual Life Outcomes. 2013 May 30;11:88. doi: 10.1186/1477-7525-11-88.